Article
Ex vivo human leukemia blood model illustrates limitations of cancer-targeting PEGylated nanoparticles
2024-05-31
Abstract excerpt
Antibody-directed targeting of chemotherapeutic nanomaterials to primary human cancers could improve efficacy and reduce off-target toxicities. We developed an ex vivo model to study the targeting of primary human Chronic Lymphocytic Leukemia (CLL) in whole blood samples from 15 subjects with CLL. Anti-CD20 targeted polyethylene glycol (PEG)-based nanoparticles had generally efficient targeting of CLL cells and lo...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced biosensing and bioanalysis techniques
- Advanced Biosensing Techniques and Applications
- Calcium signaling and nucleotide metabolism
- Chronic Lymphocytic Leukemia Research
- Complement system in diseases
- COVID-19 Impact on Reproduction
- Monoclonal and Polyclonal Antibodies Research
- Nanoparticle-Based Drug Delivery
Identifiers and source
- Literature Corpus work
- d0b08e35-0352-5ac6-9005-4741f6bb8cf9
- DOI
- 10.1101/2024.05.29.24308091
